Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma
2014 ◽
Vol 20
(2)
◽
pp. S85
◽
2009 ◽
Vol 15
(2)
◽
pp. 223-230
◽
2018 ◽
Vol 74
(5)
◽
pp. 359-363
◽
2019 ◽
Vol 25
(3)
◽
pp. S412
2013 ◽
Vol 164
(4)
◽
pp. 555-564
◽
2019 ◽
Vol 25
(3)
◽
pp. S31-S32
2019 ◽
Vol 60
(14)
◽
pp. 3434-3441
◽
2020 ◽
Vol 26
(3)
◽
pp. S21-S22